SKU: BRINZOLAST-5ML
Brinzolast Eye Drops 5ml contains Brinzolamide 1% w/v and Brimonidine 0.2% w/v. It is a prescription ophthalmic suspension used to help reduce elevated intraocular pressure in conditions such as open-angle glaucoma and ocular hypertension.
Brinzolast Eye Drops 5ml is a prescription ophthalmic suspension containing Brinzolamide 1% w/v and Brimonidine 0.2% w/v. It is used to help reduce increased pressure inside the eye in conditions such as open-angle glaucoma and ocular hypertension. The combination contains two medicines that work through different but complementary mechanisms to help control intraocular pressure.
Elevated pressure inside the eye can put stress on the optic nerve and, if left unmanaged, may contribute to vision problems. Brinzolast Eye Drops may be prescribed by an ophthalmologist as part of a treatment plan to maintain appropriate eye pressure and support long-term eye health.
Brinzolast may be prescribed for patients with open-angle glaucoma where lowering intraocular pressure is an important part of treatment. Regular use as directed by an ophthalmologist can help maintain the desired eye-pressure level.
Brinzolast can also be used in patients with ocular hypertension, a condition in which the pressure inside the eye is higher than normal without necessarily having established glaucoma. Your eye specialist will determine whether treatment is required based on your eye examination and risk factors.
For general information about glaucoma, visit MedlinePlus Glaucoma Information.
Brinzolamide is a carbonic anhydrase inhibitor. It works mainly by reducing the production of aqueous humour, the fluid naturally produced inside the eye. Reduced fluid production can help lower elevated intraocular pressure.
Brimonidine is an alpha-2 adrenergic receptor agonist. It helps reduce the production of aqueous humour and contributes to lowering pressure within the eye.
The combination of brinzolamide and brimonidine provides complementary actions for reducing elevated intraocular pressure. The two active ingredients are formulated together as an ophthalmic suspension for topical use in the eye.
Brinzolast helps reduce elevated intraocular pressure, which is an important goal in the management of glaucoma and ocular hypertension.
The formulation combines brinzolamide and brimonidine, allowing two different mechanisms to contribute to intraocular pressure control.
When prescribed by an ophthalmologist, Brinzolast can be incorporated into a glaucoma treatment plan to help maintain controlled eye pressure.
Brinzolast is supplied in a convenient 5ml eye-drop bottle for ophthalmic administration.
Brinzolamide inhibits carbonic anhydrase, an enzyme involved in aqueous humour formation. By reducing aqueous humour production, it helps decrease the amount of fluid inside the eye and can lower intraocular pressure.
Brimonidine acts on alpha-2 adrenergic receptors and reduces aqueous humour production. This helps contribute to the overall pressure-lowering effect of the combination.
The official drug information for the brinzolamide/brimonidine combination describes these complementary actions for reducing elevated intraocular pressure.
Brinzolast is an ophthalmic suspension, so the bottle should be shaken well before each use. If you have been prescribed other eye medicines, use them according to your doctor's instructions and maintain the recommended interval between different eye drops.
The commonly recommended dosage for the brinzolamide 1%/brimonidine 0.2% ophthalmic combination is one drop in the affected eye or eyes three times daily. However, the exact dose and frequency should always be determined by your ophthalmologist according to your condition and response to treatment.
Do not use Brinzolast more frequently than prescribed and do not increase the number of drops without medical advice. Consistent use according to the prescribed schedule is important for maintaining eye-pressure control.
Some patients may experience mild or temporary reactions while using Brinzolast or similar brinzolamide/brimonidine ophthalmic preparations.
Contact your doctor if side effects are severe, persistent or become troublesome. Seek prompt medical attention if you experience significant vision changes, severe eye pain, marked swelling, serious allergic symptoms or other unexpected reactions.
Temporary blurred vision may occur after applying some ophthalmic medicines. Avoid driving or operating machinery until your vision becomes clear and you know how the medicine affects you.
Tell your doctor if you are taking other glaucoma medicines, oral carbonic anhydrase inhibitors, blood-pressure medicines, medicines affecting heart function, central nervous system depressants, tricyclic antidepressants, monoamine oxidase inhibitors or high-dose salicylates.
Your healthcare professional should review your complete medication history before starting treatment, particularly if you are already taking several medicines.
If you forget to use Brinzolast, apply the missed dose when you remember unless it is nearly time for the next scheduled dose. If your next dose is due soon, skip the missed dose and continue with your regular schedule.
Do not apply extra drops to make up for a missed dose.
Store Brinzolast according to the instructions provided on the product packaging. Keep the bottle tightly closed when not in use and protect it from excessive heat and direct sunlight.
Keep Brinzolast Eye Drops out of the reach of children. Do not use the medicine if the packaging is damaged or if the product appears unsuitable for use.
For additional ophthalmic-care products, visit the BuyCenforce Eye Care Collection.
You can also explore Nataforce 5 Eye Drop 5ml and Lubimoist Eye Drops 10ml for other ophthalmic-care options.
Patients using Brinzolast for glaucoma or ocular hypertension should attend regular eye examinations as recommended by their ophthalmologist. Monitoring intraocular pressure and overall eye health helps the doctor evaluate whether the treatment is working appropriately.
Use Brinzolast at the prescribed times and continue treatment for as long as your doctor recommends. Do not discontinue treatment simply because your eyes feel normal, as elevated eye pressure may not always cause noticeable symptoms.
Brinzolast Eye Drops is used to help reduce elevated intraocular pressure in conditions such as open-angle glaucoma and ocular hypertension.
Brinzolast contains Brinzolamide 1% w/v and Brimonidine 0.2% w/v.
The commonly recommended dosage is one drop in the affected eye or eyes three times daily. Your ophthalmologist may prescribe a different schedule depending on your condition.
Yes. Brinzolast is an ophthalmic suspension and should be shaken well before each use.
Other eye drops may sometimes be prescribed together with Brinzolast. Follow your ophthalmologist's instructions and maintain the recommended interval between different ophthalmic medicines.
Yes. Brinzolast should be used under the supervision and direction of a qualified healthcare professional.
This information is provided for educational purposes only and should not replace professional medical advice, diagnosis or treatment. Brinzolast Eye Drops should be used only as prescribed or recommended by a qualified healthcare professional. Do not self-medicate, change the dosage or discontinue treatment without consulting your doctor.
For additional reliable information about glaucoma, you can refer to MedlinePlus and the National Eye Institute glaucoma information. For official prescribing information regarding brinzolamide/brimonidine ophthalmic suspension, refer to DailyMed.
| Brand | Ocularis |
| Manufacturer | Mankind Pharma Ltd |
| Composition | Brinzolamide 1% w/v + Brimonidine 0.2% w/v |
| Package | 5ml Ophthalmic Eye Drop Bottle |
| Ship time | 5-10 Business Days |
Free Shipping
For all oders over $99
Secure Payment
100% secure payment
24/7 Support
Online top support